MTOR and digestive system neoplasm: A previous retrospective study involving 45 dMMR/MSI-H gastrointestinal tumors (18 gastric tumors) suggests that the mutation of PTEN, a key member of the PI3K-AKT-mTOR pathway, was associated with poor response to ICIs [45].